Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2011-12-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Across Multiple Types of Sleep Deprivation
NCT04211506
Comparison of RT in Patients With Sleep Apnea With and Without Complaints of Daytime Sleepiness
NCT01562262
Effects of Time of Sleep Restriction in Obesity
NCT01259895
The Effect of Sleep Loss on Emotion Regulation
NCT05393830
Age-related Changes in Sleep-wake Regulation
NCT03813082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Men with Total Sleep Time ≤ 6h that will undergo 25 percent of chronic sleep restriction of their TST
Chronic Sleep Restriction
All volunteers will undergo 25% of sleep restriction of their total sleep time at the beginning sleep for five consecutive days. The nights will be monitored by polysomnography.
Group 2
Men with Total Sleep Time (range 7-8h)that will undergo 25 percent of chronic sleep restriction of their TST
Chronic Sleep Restriction
All volunteers will undergo 25% of sleep restriction of their total sleep time at the beginning sleep for five consecutive days. The nights will be monitored by polysomnography.
Group 3
Men with Total Sleep Time ≥ 9h that will undergo 25 percent of chronic sleep restriction of their TST
Chronic Sleep Restriction
All volunteers will undergo 25% of sleep restriction of their total sleep time at the beginning sleep for five consecutive days. The nights will be monitored by polysomnography.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chronic Sleep Restriction
All volunteers will undergo 25% of sleep restriction of their total sleep time at the beginning sleep for five consecutive days. The nights will be monitored by polysomnography.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physically active individuals
* 8 years of school education.
Exclusion Criteria
* High level of anxiety - Beck Depression Inventory ≥ 19
* PSQI - Pittsburgh Sleep Quality Index ≥ 11
* ESS - Epworth Sleepiness Scale ≥ 15
* Irregular rhythm of sleep identified by actigraphy
* Sleep disturbance by polysomnography
* Shift worker or nocturnal worker;
* Obesity;
* Smoker;
* Alcohol Intake of more than 3 drinks per day;
* Taking sleep medications or illicit drugs.
20 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Associação Fundo de Incentivo à Pesquisa
OTHER
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marco Tulio de Mello
Ph.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco T De Mello, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Juliana MS Prado, Ph.D
Role: STUDY_CHAIR
Federal University of São Paulo
Patricia Rzezak, Ph.D
Role: STUDY_CHAIR
Federal University of São Paulo
Sergio Tufik, Ph.D
Role: STUDY_CHAIR
Federal University of São Paulo
Sandra S De Queiroz
Role: STUDY_CHAIR
Federal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Sao Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Fundação de Amparo à Pesquisa do Estado de São Paulo
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEPE2011SSQueiroz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.